Neodent

Discussion in 'Straumann' started by Anonymous, Dec 16, 2013 at 6:19 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I just had a doc that I have been prospecting tell me he is thinking about leaving Straumann because of the high prices and is looking at a company called neodent out of Brazil. He was shocked when I told him it's the same company. He said he stopped by the booth at the Seattle meeting and never did they mentioned that Straumann owns them.
    Thanks Straumann you are making my job alot easier with all the confusion you are doing.
     

  2. Anonymous

    Anonymous Guest

    Megagen is their newest aquisitition. Just posted yesterday.
     
  3. Anonymous

    Anonymous Guest

    Are layoffs coming?
     
  4. Anonymous

    Anonymous Guest

    Marco Gadola, Straumann's CEO, explained the rationale for the transaction: "Straumann is fully committed to being the partner of choice in the premium segment of implant dentistry, offering an excellent combination of innovation, quality, support, clinical documentation, expertise and peace of mind. However, some dentists are willing to pay for lower standards than those offered by premium brands, which has fueled growth in the value segment. To address their requirements and to capture this significant business opportunity, we are building a platform of value brands, in which MegaGen will have an important role. MegaGen is a dynamic company with a growing footprint in key value markets. The convertible bond offers us strategic flexibility with controlled risk and a great opportunity to penetrate the value segment in Asia/Pacific".

    Amazing that the CEO would comment - "some dentist are willing to pay for lower standards". I am sure the dentist that write checks to Straumann every month that use Neodent and MegaGen will be happy to know they are using lower standard products.
     
  5. Anonymous

    Anonymous Guest

    You know that Straumann doesn't 'own' Neodent (49% is not 'owning' according to my economics book, though they are a major share holder and work closely with Neodent by sharing backoffice resources in North America). So you were basically lying to your customer. LOL.
     
  6. Anonymous

    Anonymous Guest

    For years all I heard about was Straumann does not sell on price and would never offer a low cost low standered implant. I love how things have changed its OK Straumann losers to admit defeat and that you have been wrong and now want to sell on price with cheap implants and knock off parts.
    I thought you did not want to sell and train GP'S to place implants??
    This is Like Your Regen Division OR Guided Surgery Division
    Straumann stock is sinking and this is the last call for help
    I am glad to see you finally go against everything you preach can't wait to show my docs they are overpaying for implants or gave a low standered if care for placing neodent.
     
  7. Anonymous

    Anonymous Guest

    And I'm kind a glad that you don't get it. You will be long gone while your and their customers remain in business and will have the choice between premium and value solutions. Whatever they'll pick money will flow into Straumann share holder's pockets. Have you checked Straumann stock lately? A year ago they were at 128 francs a share. Now they are at 190. Think again on what horse you place your bets. It's never too late to change your ways of approaching things. Like Straumann.....
     
  8. Anonymous

    Anonymous Guest

    Neodent is going down in flames…. The President (not sure what his real title is, he is all about titles and tells everybody he is the President) running the U.S. launch Tony Susino thinks he a big time corporate executive on Wall Street and in reality he is just a low level corporate trainer that has no experience at all with making a physical sales call. His arrogance is so big one can't even breath while being in a room with Tony. Straumann is currently looking into Mr. Susino for his outlandish spending habits with their corporate credit card. Neodent started out with 15 reps last January and are down to 10 from rep's quitting. Others are getting ready to quit….
     
  9. Anonymous

    Anonymous Guest

    This is a ridiculous post. TS was with Straumann for 8 years prior to this appointment, including his most recent position as VP of strategic events- for Straumann. So if any of his actions, decisions, or lack of leadership ability comes as a surprise- it's their own fault.

    Glad to see the cheap ship going down in flames- just like their biologics division did. Not all that glitters is gold- just like Nobel, and just like Astra. Empty corporate shells throwing around big bucks.
     
  10. Anonymous

    Anonymous Guest

  11. Anonymous

    Anonymous Guest

    Nobel Biocare Holding AG
    NOBEL BIOCARE SUES NEODENT USA FOR PATENT INFRINGEMENT
    Two subsidiaries of Nobel Biocare Holding AG, a world leader in the field of innovative implant-based dental restorations, filed a patent infringement lawsuit today in California against Neodent USA, Inc., alleging infringement of two patents relating to the innovative design of Nobel Biocare's popular NobelActive®line of dental implants.

    In March 2014, Neodent USA launched its line of "Drive CM" dental implants in the US. In its complaint, Nobel Biocare alleges that these implants, imported from Brazil, have striking similarities to the design of the NobelActive®implants which Nobel Biocare commercially launched in 2008. Further, Nobel Biocare asserts that Neodent USA has relied on Nobel Biocare's history of successful clinical data in marketing the Neodent product.

    The NobelActive®line has grown to become one of the world's most popular dental implants, supported by Nobel Biocare's commitment to Research & Development (R&D) spending, extensive clinical studies, and training programs for clinicians. Both US patents asserted in the lawsuit relate to technology for aiding the surgical installation and successful integration of the implants in a variety of patient bone types. Nobel Biocare asks the court for an injunction barring sales of Neodent's infringing dental implants, payment of money damages due to Nobel Biocare's lost sales, and to recover its attorney fees for the lawsuit.
     
  12. Anonymous

    Anonymous Guest

    Neodent USA contests Nobel Biocare’s allegations of patent infringement in the USA
    20-08-2014
    Andover, MA, August 20, 2014 - In response to the recent announcement made by Nobel Biocare Holding AG, Neodent USA said today that it intends to vigorously defend itself against Nobel’s allegations of patent infringement relating to one of its
    range of implants.

    The implant in question, Neodent’s Drive CM, is one of several implants that the company introduced in the USA in March, which offer excellent alternatives for dentists and patients who want high quality, state-of-the-art, proven implant solutions at an attractive competitive price.

    Prior to launching Drive CM, Neodent obtained in-depth evaluations to ensure that its designs respected all valid intellectual property rights. Drive CM incorporates features, such as an innovative connection, which differentiate it from Nobel Biocare’s implant. The current complaint appears to be based on patents that Nobel Biocare obtained after Drive CM was introduced in the USA. Neodent is looking into the allegations carefully and will respond appropriately.

    “The preliminary design of NobelActive® was invented and developed by an Israeli team at AlphaBioTec Ltd – not originally by Nobel Biocare, as many people believe. We did our homework before launching our range of implants in the US, especially the Drive CM, and we are confident that we have not infringed any patents”, said Tony Susino, CEO of Neodent USA. “In its media release, Nobel Biocare has sent a clear signal to the dental community that our implant is ‘strikingly similar’ to theirs. Nobel sees that we have a very attractive, high quality alternative.”

    Neodent relies on a strong clinical track record that has been built up over 20 years. Its proven system has earned the trust of more than 30,000 clinicians, and the company has sold well over five million implants worldwide. Like most implant systems, its products are supported by the company’s own clinical experience as well as clinical and scientific findings published by third parties in the public domain – for example concerning high grade titanium, implant designs, surface technology, etc. Most companies rely on third-party documentation in applications for regulatory approvals based on substantial equivalence.

    About Neodent
    Founded in 1993, Neodent is Latin America’s leading dental implant company. It was the first Brazilian company in the implant sector to receive certification from the Ministry of Health. The company opened its own premises in Curitiba in 1998, where its headquarters and a state-of-the-art manufacturing facility are located.

    Neodent employs more than 900 employees, operates more than 21 branches in Brazil and works with a wide network of distributors positioning the company as the market leader in the LATAM region. Neodent also has subsidiaries and distributors in other geographies targeting the non-premium segment in these markets. It places considerable importance on education and training with the aim of ensuring quality treatment standards and patient care. It does this through the ILAPEO (The Latin American Institute of Dental Research and Education), one of the largest dedicated implant training centers in the world, offering courses to thousands of participants from all over the world each year.

    ____________________________________________________________________
    Neodent USA, Inc. 60 Minuteman Road, Andover, MA 01810
    Phone (855) 412-8883
    Email: info@neodentusa.com
    Homepage: www.neodentusa.com
    Twitter: @neodentusa.com
    Facebook: facebook.com/neodentusa
    LinkedIn: http://www.linkedin.com/company/neodent-usa-inc
    Google+: plus.google.com/neodentusa
    YouTube: www.youtube.com/neodentusa

    Contacts:
    USA
    Bill Benjaminsen: +1 (978) 269-6366
     
  13. Anonymous

    Anonymous Guest

    Straumann fired Tony Susino. Neodent is a mess.... Now down to less that 6reps in the US. This company won't be around much longer.....
     
  14. Anonymous

    Anonymous Guest

    No one was fired! Maybe you should get your facts correct before posting them. He left and is moving out of the state. And we have way more then 6 reps. Another false comment.. Any others?? Because I can keep going.

    We are also bussier then ever and switching ALOT of doctors over.. :)
     
  15. Anonymous

    Anonymous Guest

    Left for Camlog and the state is Califoronia, he has left a sinking ship with no rudder
     
  16. Anonymous

    Anonymous Guest

    didn't the "Mutt" Rebeka also leave Straumann for Camlog? make that two sinking ships then.
     
  17. Anonymous

    Anonymous Guest

    Straumann is garbage
     
  18. Anonymous

    Anonymous Guest

    Says the Implant Direct Rep that couldn't get a job a Straumann. Keep swimming...
     
  19. Anonymous

    Anonymous Guest

    Straumann has signed an agreement to increase its ownership of Neodent, Latin America’s leading dental implant company, from 49% to 100% in 2015, three years earlier than foreseen in a previous option agreement. The purchase price for the outstanding 51% is BRL 680 million (approximately CHF 210 million ) paid in cash to the company’s founding shareholders, Drs Clemilda de Paula Thomé and Geninho Thomé. The acquisition extends Straumann’s overall leadership in implant dentistry and makes the Group a substantial contender in the global value segment.
     
  20. Anonymous

    Anonymous Guest


    here come more paycuts!